Navigating Investment Pathways for Startup Companies Within the Nasal Space
Time: 9:00 am
day: Day 1
Details:
- Emphasis on presenting strong preclinical and early clinical data that demonstrate the safety, efficacy, and unique benefits of the intranasal drug, showcasing its potential for market success
- Discussion of the importance of articulating a compelling value proposition that outlines the product’s competitive advantages, potential market impact, and alignment with current healthcare trends
- Insights into building strategic partnerships with industry leaders and highlighting any existing funding or collaborations that enhance credibility
